Glypican 2

Glypican 2 詳細

英語名Glypican-2市販薬剤の数0
治験薬の数2ターゲットの別称Cerebroglycan,Glypican Proteoglycan 2, Cerebroglycan Proteoglycan
研究&開発段階Phase 1 Clinical
英語名Glypican-2
ターゲットの別称Cerebroglycan,Glypican Proteoglycan 2, Cerebroglycan Proteoglycan
市販薬剤の数0
治験薬の数2
研究&開発段階Phase 1 Clinical

Glypican 2 製品リスト

  • 属性

    Protein (7)

  • 製品ライブラリ

    オンライン (7)

  • 種

    Human (4)Mouse (1)Rhesus macaque (2)

  • タグ

    His Tag (3)Fc Tag (1)Llama IgG Fc Tag (1)His Tag & Avi Tag (2)

  • マーカー

    Unconjugated (5)Biotin-labeled (2)

Glypican 2バックグランド

Glypican 2 (GPC2), also known cerebroglycan, is a glycophosphatidylinositol-linked integral membrane heparan sulfate proteoglycan found in the developing nervous system. Cerebroglycan participates in cell adhesion and is thought to regulate the growth and guidance of axons. Cerebroglycan has especially high affinity for laminin-1. GPC2 silencing inactivates Wnt/β-catenin signaling and reduces the expression of N-Myc, an oncogenic driver of neuroblastoma tumorigenesis. Immunotoxins and chimeric antigen receptor (CAR) T cells targeting GPC2 inhibit neuroblastoma growth in mouse models. A GPC3 specific antibody drug conjugate (ADC) can also inhibit neuroblastoma cell proliferation.

Glypican 2分子の別称

Glypican 2,GPC2

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
anti-glypican-2 CAR T-cell therapy (Childrens Hospital of Philadelphia/Kite Pharma)Phase 1 ClinicalChildrens Hospital of PhiladelphiaRhabdomyosarcoma; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma
詳細
GPC2 CAR-T cell therapy(Childrens Hospital of Philadelphia/Tmunity Therapeutics)TmGPC2-01-CAR-TPhase 1 ClinicalChildrens Hospital of PhiladelphiaSmall Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報